Circulating Tumor Cell: Clinical Trials

1 trial for Circulating Tumor Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Circulating Tumor Cell: new trials by email Literature Review of Circulating Tumor Cell trials Research Report on Circulating Tumor Cell

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer
Pertuzumab, Trastuzumab, Circulating tumor cells - Breast Neoplasms, HER2-positive Breast Cancer
Phase 2RecruitingAC Camargo Cancer Center802021-03-012021-08-06

Narrower conditions

Breast Neoplasms (1)  ·  Neoplastic Cells, Circulating (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Trastuzumab (1)  ·  pertuzumab (1)

Sponsors

AC Camargo Cancer Center (1)

Countries

Brazil (1)

Top investigators

Marcelle G Cesca, MD (1)